Red wine may be used in the therapy of myocarditis

Journal of Cellular Biochemistry

Volumn 111, Issue 4, 2010, Pages 808-810

  Chen, Chun Juan ^a   Yu, Wei ^a   Wang, Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Inflammation; Myocarditis; Red wine; Therapeutics

Indexed keywords

CYTOKINE; RESVERATROL; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL PRACTICE; CYTOKINE PRODUCTION; HEART MUSCLE INJURY; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; MYOCARDITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RECURRENT DISEASE; RED WINE;

CYTOKINES; HUMANS; MYOCARDITIS; TRANSCRIPTION FACTORS; WINE;

EID: 78049275832     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22882     Document Type: Article

References (40)

1. Arbabi S, Garcia I, Bauer GJ, Maier RV. 1999. Alcohol (ethanol) inhibits IL-8 and TNF: Role of the p38 pathway. J Immunol 162: 7441-7445.
2. Arend WP, Dayer JM. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 38: 151-160.
3. Avellone G, Di Garbo V, Campisi D, De Simone R, Raneli G, Scaglione R, Licata G. 2006. Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. Eur J Clin Nutr 60: 41-47.
4. Azuma RW, Suzuki J, Ogawa M, Futamatsu H, Koga N, Onai Y, Kosuge H, Isobe M. 2004. HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation. Cardiovasc Res 64: 412-420.
5. Blanco-Colio LM, Valderrama M, Alvarez-Sala LA, Bustos C, Ortego M, Hernández-Presa MA, Cancelas P, Gómez-Gerique J, Millán J, Egido J. 2000. Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation 102: 1020-1026.
6. Bode AM, Dong Z. 2003. Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci STKE 167: RE2.
7. Butler DM, Maini RN, Feldmann M, Brennan FM. 1995. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw 6: 225-230.
8. Canali R, Vignolini F, Nobili F, Mengheri E. 2000. Reduction of oxidative stress and cytokine-induced neutrophil chemoattractant (CINC) expression by red wine polyphenols in zinc deficiency induced intestinal damage of rat. Free Radic Biol Med 28: 1661-1670.
9. Cooper LT Jr. 2009. Myocarditis. N Engl J Med 360: 1526-1538.
10. de la Lastra CA, Villegas I. 2005. Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol Nutr Food Res 49: 405-430.
11. Dorai T, Aggarwal BB. 2004. Role of chemopreventive agents in cancer therapy. Cancer Lett 215: 129-140.
12. Drory Y, Turetz Y, Hiss Y, Lev B, Fisman EZ, Pines A, Kramer MR. 1991. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 168: 1388-1392.
13. Estruch R, Sacanella E, Badia E, Antúnez E, Nicolás JM, Fernández-Solá J, Rotilio D, de Gaetano G, Rubin E, Urbano-Márquez A. 2004. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: A prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 175: 117-123.
14. Feldman AM, McNamara D. 2000. Myocarditis. N Engl J Med 343: 1388-1398.
15. Feng AN, Chen YL, Chen YT, Ding YZ, Lin SJ. 1999. Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-Fed rabbits. Circulation 100: 2254-2259.
16. Feng YH, Zou JP, Li XY. 2002. Effects of resveratrol and ethanol on production of pro-inflammatory factors from endotoxin-activated murine macrophages. Acta Pharmacol 23: 1002-1006.
17. Grønbaek M, Becker U, Johansen D, Gottschau A, Schnohr P, Hein HO, Jensen G, Sørensen TI. 2000. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 133: 411-419.
18. Kang OH, Jang HJ, Chae HS, Oh YC, Choi JG, Lee YS, Kim JH, Kim YC, Sohn DH, Park H, Kwon DY. 2009. Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: Pivotal roles of NF-kappaB and MAPK. Pharmacol Res 59: 330-337.
19. Karin M, Delhase M. 1998. JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action? Proc Natl Acad Sci USA 95: 9067-9069.
20. Karin M, Liu Z, Zandi E. 1997. AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246.
21. Kawai C. 1999. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future. Circulation 99: 1091-1100.
22. Kong G, Kim EK, Kim WS, Lee KT, Lee YW, Lee JK, Paik SW, Rhee JC. 2002. Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer. J Gastroenterol Hepatol 17: 914-921.
23. Kundu JK, Surh YJ. 2004. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res 555: 65-80.
24. Magrone T, Jirillo E. 2010. Polyphenols from red wine are potent modulators of innate and adaptive immune responsiveness. Proc Nutr Soc 69: 279-285.
25. Magrone T, Candore G, Caruso C, Jirillo E, Covelli V. 2008a. Polyphenols from red wine modulate immune responsiveness: Biological and clinical significance. Curr Pharm Des 14: 2733-2748.
26. Magrone T, Tafaro A, Jirillo F, Amati L, Jirillo E, Covelli V. 2008b. Elicitation of immune responsiveness against antigenic challenge in age-related diseases: Effects of red wine polyphenols. Curr Pharm Des 14: 2749-2757.
27. Manna SK, Mukhopadhyay A, Aggarwal BB. 2000. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164: 6509-6519.
28. Marfella R, Cacciapuoti F, Siniscalchi M, Sasso FC, Marchese F, Cinone F, Musacchio E, Marfella MA, Ruggiero L, Chiorazzo G, Liberti D, Chiorazzo G, Nicoletti GF, Saron C, D'Andrea F, Ammendola C, Verza M, Coppola L. 2006. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus. Diabet Med 23: 974-981.
29. Martinez J, Moreno J. 2000. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 59: 865-870.
30. Pervaiz S. 2003. Resveratrol: From grapevines to mammalian biology. FASEB J 17: 1975-1985.
31. Royer B, Varadaradjalou S, Saas P, Gabiot AC, Kantelip B, Féger F, Guillosson JJ, Kantelip JP, Arock M. 2001. Autocrine regulation of cord blood-derived human mast cell activation by IL-10. J Allergy Clin Immunol 108: 80-86.
32. Stassen M, Müller C, Arnold M, Hültner L, Klein-Hessling S, Neudörfl C, Reineke T, Serfling E, Schmitt E. 2001. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol 166: 4391-4398.
33. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, Dannenberg AJ. 1998. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273: 21875-21882.
34. Szabo G, Mandrekar P, Girouard L, Catalano D. 1996. Regulation of human monocyte functions by acute ethanol treatment: Decreased tumor necrosis factor-alpha, interleukin-1beta and elevated interleukin-10, and transforming growth factor-beta production. Alcohol Clin Exp Res 20: 900-907.
35. Uhl TL. 2008. Viral myocarditis in children. Crit Care Nurse 28: 42-63.
36. Urquiaga I, Strobel P, Perez D, Martinez C, Cuevas A, Castillo O, Marshall G, Rozowski J, Leighton F. 2010. Mediterranean diet and red wine protect against oxidative damage in young volunteers. Atherosclerosis 211: 694-699.
37. Verma BK, Fogarasi M, Szabo G. 1993. Down-regulation of TNF-α activity by acute ethanol treatment in human peripheral blood monocytes. J Clin Immunol 13: 8-22.
38. Wang ZP, Hua YM, Zhang X, Wang YB, Shi XQ, Li MY. 2009. Effect of resveratrol on myocardial fibrosis in mice with chronic viral myocarditis. Zhongguo Dang Dai Er Ke Za Zhi 11: 291-295.
39. Yoshida Y, Shioi T, Izumi T. 2007. Resveratrol ameliorates experimental autoimmune myocarditis. Circ J 71: 397-404.
40. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103: 779-788.